2012
DOI: 10.1074/mcp.m111.015750
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Targets of c-Src Tyrosine Kinase by Chemical Complementation and Phosphoproteomics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
54
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 53 publications
(63 citation statements)
references
References 68 publications
4
54
0
Order By: Relevance
“…It requires an internalization motif, 20 YTRF 23 , found in its 67-amino acid N-terminal cytoplasmic domain (8). Src can phosphorylate 20 Y of the internalization sequence (9).…”
mentioning
confidence: 99%
“…It requires an internalization motif, 20 YTRF 23 , found in its 67-amino acid N-terminal cytoplasmic domain (8). Src can phosphorylate 20 Y of the internalization sequence (9).…”
mentioning
confidence: 99%
“…SILAC medium was prepared as previously reported 10 . In brief, arginine- and lysine-free DMEM was supplemented with either light amino acids or heavy amino acids.…”
Section: Methodsmentioning
confidence: 99%
“…Previously, for the non-receptor tyrosine kinases Src, v-Src and Csk, a mutant chemical rescue approach was reported and used to obtain insights into the cellular functions of these enzymes 810 . In this technique, a conserved active site Arg is replaced with Ala which sharply reduces catalytic activity, and this reduced activity can be complemented with the small molecule imidazole 11, 12 .…”
Section: Introductionmentioning
confidence: 99%
“…Recently, some studies have reported that the overexpression of wild Src can promote the activity of other signaling pathway molecules (Elsberger et al, 2010;Yasmeen et al, 2010). In fact, Src kinase has been proven to be able to react with a variety of proteins, including receptor tyrosine kinase-colony-stimulating factor receptor-1, plateletderived growth factor receptor, vascular endothelial growth factor receptor, human epidermal growth factor receptor-2, and human epidermal growth factor receptor-3 (Ferrando et al, 2012;Nagaraj et al, 2013). Other acting factors include signal transduction and transcription activation factors, heterotrimeric G protein, mitogen-activated protein kinase (MAPK), cyclin D and E, and focal adhesion kinase (Khoury et al, 2009).…”
Section: Discussionmentioning
confidence: 99%